News

Title	GENUV CEO Sung-Ho Han, "To make real progress in the treatment of ALS and give hope to the patients"	2020-03-04
Link : https://www.mk.co.kr/news/it/view/2020/03/225174/
Prev	Genuv Unveils GNUV205, a Bifunctional Fusion Protein That Potently Regresses Tumor Growth Without Toxicity
Next	GENUV, Receives Approval for ALS Phase 1·2a Clinical Studies on New Drug Candidate